Saturday, October 31, 2026

EUR/CHF Bullish Momentum With A 2% Jump In The Last 21 Sessions

EUR/CHF Bullish Momentum With A 2% Jump In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 2% for the last 21 sessions. At 19:06 EST on Thursday, 7 March, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 6.401% up from its 52-week low and 3.882% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was 0.18%, 0.13%, and 0.23%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.25% (last week), 0.23% (last month), and 0.23% (last quarter), respectively.

News about

  • Usd/jpy price analysis: is another top forming?. According to FXStreet on Wednesday, 6 March, "Over time this has acted as a negative factor for JPY and driven the USD/JPY to new highs.", "As can be seen on the weekly chart above, after peaking at 150.84 last week, USD/JPY has entered the zone of previous major highs in the 151s - possibly a sign it is topping - however, there has so far been insufficient downside price action to definitively say it is rolling over."
  • According to FXStreet on Wednesday, 6 March, "Some follow-through buying beyond the 151.00 mark will reaffirm the positive bias and lift the USD/JPY pair to the 151.45 hurdle. ", "The subsequent downfall could drag the USD/JPY pair to the 148.30 support en route to the 148.00 mark and the 100-day Simple Moving Average (SMA), currently pegged near the 147.75 region."
  • According to FXStreet on Thursday, 7 March, "The USD/JPY pair might then surpass the 150.40-150.50 hurdle and make a fresh attempt to conquer the 151.00 round-figure mark.", "Some follow-through selling below the 23.6% Fibonacci retracement level of the December-February rally, around the 148.40-148.35 region, will reaffirm the bearish setup and drag the USD/JPY pair to the 148.00 mark. "
  • Usd/jpy: more room for losses unless Friday’s US data are strong – socgen. According to FXStreet on Thursday, 7 March, "Yen short covering is helped by lower US yields and unless Friday's US data are strong, there's more room for USD/JPY to fall."
  • Usd/jpy plunges to 148.00 as Japanese yen strengthens on hawkish boj bets. According to FXStreet on Thursday, 7 March, "The USD/JPY plummets to 148.00 in Thursday's European session as expectations for the Bank of Japan (BoJ) lifting negative interest rates have escalated. ", "Meanwhile, weak US Dollar has also resulted in downward pressure on the USD/JPY pair. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com